101 related articles for article (PubMed ID: 13028)
1. [Pressor action of propranolol; with special reference to relationship between the pressor action and peripheral vascular tone].
Yamamoto J; Maekawa H; Sekiya A
Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):709-14. PubMed ID: 13028
[TBL] [Abstract][Full Text] [Related]
2. [Action of propranolol on the perfusion pressure into the peripheral vasculature of rat hindquarters].
Maekawa H; Sekiya A; Nomura H; Yamamoto J
Nihon Yakurigaku Zasshi; 1984 Jan; 83(1):11-5. PubMed ID: 6325312
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: On the pressor action of propranolol in the rat. 5.
Sekiya A; Yamamoto J; Maekawa H
Jpn J Pharmacol; 1974; 24(0):s:70. PubMed ID: 4545623
[No Abstract] [Full Text] [Related]
4. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
5. Further studies on the pressor action of propranolol in the rat.
Yamamoto J; Sekiya A
Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):347-54. PubMed ID: 4403390
[No Abstract] [Full Text] [Related]
6. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
7. Effects of several beta-blockers on blood pressure in the rat.
Yamamoto J; Sekiya A; Maekawa H
Jpn J Pharmacol; 1975 Aug; 25(4):465-71. PubMed ID: 1562
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
Maekawa H
Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
[TBL] [Abstract][Full Text] [Related]
9. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
Burnier M; Biollaz J; Brunner DB; Gavras H; Brunner HR
J Pharmacol Exp Ther; 1983 Jan; 224(1):222-7. PubMed ID: 6129318
[No Abstract] [Full Text] [Related]
10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular actions of optical isomers of propranolol.
Yamamoto J; Sekiya A; Maekawa H; Kato Y
Jpn J Pharmacol; 1978 Aug; 28(4):627-31. PubMed ID: 32418
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
Branch CA; Knuepfer MM
J Pharmacol Exp Ther; 1992 Nov; 263(2):742-51. PubMed ID: 1359113
[TBL] [Abstract][Full Text] [Related]
15. Effect of fibrinogen degradation products on the rat blood vessels.
Buczko W
Acta Physiol Pol; 1977; 28(2):153-9. PubMed ID: 868533
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
Lenke D; Gries J; Kretzschmar R
Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
[TBL] [Abstract][Full Text] [Related]
17. The site and the mechanism of phenoxy-benzamine potentiation of the pressor response to oxytocin and vasopressin: in vivo and isolated aortic strips studies.
Erker EF; Chan WY
J Pharmacol Exp Ther; 1977 Aug; 202(2):287-93. PubMed ID: 886467
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
Cavero I; Lefèvre-Borg F; Gomeni R
J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059.
Pittner H; Stormann H; Enzenhofer R
Arzneimittelforschung; 1976; 26(12):2145-54. PubMed ID: 66056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
